Renaissance Capital’s GoodRx Holdings GDRX Stock Holding History

Renaissance Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,622	Closed	-$399K	–	84
2022 Q1	$399K	Sell	20,622 -6,175	-23%	-$142K	0.17%	83
2021 Q4	$876K	Sell	26,797 -4,695	-15%	-$189K	0.22%	71
2021 Q3	$1.29M	Sell	31,492 -44,056	-58%	-$1.6M	0.26%	63
2021 Q2	$2.72M	Buy	75,548 +19,070	+34%	+$704K	0.43%	45
2021 Q1	$2.2M	Sell	56,478 -9,160	-14%	-$412K	0.33%	50
2020 Q4	$2.65M	Buy	+65,638	New	+$3.02M	0.36%	39

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Renaissance Capital's GDRX Position: Q2 2022 in Review

Renaissance Capital sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 20,622 shares — an estimated $399K sold.

Renaissance Capital first reported a position in GDRX in Q4 2020 and held it in 6 quarters. The position peaked at $2.72M in Q2 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

Renaissance Capital reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
Renaissance Capital sold 20,622 GoodRx Holdings shares in Q2 2022, an estimated $399K.
Renaissance Capital first reported a position in GoodRx Holdings in Q4 2020 and held it in 6 quarters.
Renaissance Capital's GoodRx Holdings position peaked at $2.72M in Q2 2021.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Renaissance Capital's 13F filing for Q2 2022, filed 11 Jul 2022.